High pulse pressure and metabolic syndrome are associated with proteinuria in young adult women

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Kim, Jwa Kyung ^a   Ju, Young Su ^b   Moon, Sung Jin ^c   Song, Young Rim ^a   Kim, Hyung Jik ^a   Kim, Sung Gyun ^a  

^a Hallym University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; DIAGNOSTIC TEST; DIPSTICK; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MASS SCREENING; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PROTEINURIA; PULSE PRESSURE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CAUSALITY; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; METABOLIC SYNDROME X; OBESITY; PROTEINURIA; REPUBLIC OF KOREA; RISK FACTORS; WOMEN'S HEALTH;

EID: 84874001978     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-45     Document Type: Article

References (32)

1. Proteinuria and the risk of developing end-stage renal disease. Iseki K, Ikemiya Y, Iseki C, Takishita S, Kidney Int 2003 63 1468 1474 (Pubitemid 36350012)
2. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M, Stroke 1996 27 2033 2039 (Pubitemid 26372576)
3. Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT research group. Multiple risk factor intervention trial. Grimm RH Jr, Svendsen KH, Kasiske B, Keane WF, Wahi MM, Kidney Int 1997 63 Suppl 10 S14
4. Microalbuminuria as predictor of increased mortality in elderly people. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE, BMJ 1990 300 297 300 (Pubitemid 20047068)
5. Microalbuminuria in the US population: third national health and nutrition examination survey. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, Kusek JW, Byrd-Holt D, Narayan KM, Herman WH, Jones CP, Salive M, Agodoa LY, Am J Kidney Dis 2002 39 445 459 (Pubitemid 34194620)
6. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD, Clin J Am Soc Neprhol 2011 6 2364 2373
7. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Chen B, Yang D, Chen Y, Xu W, Ye B, Ni Z, Clin Chim Acta 2010 411 705 709
8. Obesity-related glomerulopathy: an emerging epidemic. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD, Kidney Int 2001 59 1498 1509 (Pubitemid 32281241)
9. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Tozawa M, Iseki C, Tokashiki K, Chinen S, Kohagura K, Kinjo K, Takishita S, Iseki K, Hypertens Res 2007 30 937 943 (Pubitemid 350120971)
10. Metabolic syndrome and the development of CKD in american indians: the strong heart study. Lucove J, Vupputuri S, Heiss G, North K, Russell M, Am J Kidney Dis 2008 51 21 28 (Pubitemid 350296515)
11. Pregnancy in CKD: whom should we follow and why? Piccoli GB, Fassio F, Attini R, Parisi S, Biolcati M, Ferraresi M, Pagano A, Daidola G, Deagostini MC, Gaglioti P, Todros T, Nephrol Dial Transplant 2012 27 Suppl 3 111 118
12. asymptomatic mild intermittent proteinuria; a percutaneous renal biopsy study. Muth RG, Arch Intern Med 1965 115 569 574
13. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), Ann Intern Med 2009 150 604 612
14. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001 285 2486 2497
15. Diagnosis and management of the metabolic syndrome: an american heart association/national heart, lung, and blood institute scientific statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Jr Spertus JA, Costa F, American Heart Association; National Heart, Lung, and Blood Institute, Circulation 2005 112 2735 2752 (Pubitemid 41532612)
16. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Alberti KG, Zimmet P, Shaw J, Diabet Med 2006 23 469 480
17. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. Woolhandler S, Pels RJ, Bor DH, Himmelstein DU, Lawrence RS, JAMA 1989 262 1214 1219
18. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S, Kidney Int 2002 62 1743 1749 (Pubitemid 35286282)
19. Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ, Circulation 2005 112 666 673 (Pubitemid 41099045)
20. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem. Iseki K, J Nephrol 2008 21 305 312
21. Leptin and renal disease. Wolf G, Chen S, Han DC, Ziyadeh FN, Am J Kidney Dis 2002 39 1 11 (Pubitemid 34062489)
22. The vascular protective effects of estrogen. Farhat MY, Lavigne MC, Ramwell PW, FASEB J 1996 10 615 624 (Pubitemid 26141172)
23. Sex difference in cardiovascular risk: role of pulse pressure amplification. Regnault V, Thomas F, Safar ME, Osborne-Pellegrin M, Khalil RA, Pannier B, Lacolley P, J Am Coll Cardiol 2012 59 1771 1777
24. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Pedrinelli R, Dell'Omo G, Penno G, Bandinelli S, Bertini A, Di Bello V, Mariani M, Hypertension 2000 35 48 54 (Pubitemid 30054236)
25. Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure? Farasat SM, Valdes C, Shetty V, Muller DC, Egan JM, Metter EJ, Ferrucci L, Najjar SS, Hypertension 2010 55 415 421
26. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. O'Rourke MF, Safar ME, Hypertension 2005 46 200 204 (Pubitemid 40946514)
27. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Ito S, Nagasawa T, Abe M, Mori T, Hypertension Res 2009 32 115 121
28. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in type 2 diabetic subjects. Knudsen ST, Jeppesen P, Frederiksen CA, Andersen NH, Bek T, Ingerslev J, Mogensen CE, Poulsen PL, Diabet Med 2007 24 911 915 (Pubitemid 47093053)
29. Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease. Beigel R, Dvir D, Arbel Y, Shechter A, Feinberg MS, Shechter M, Vasc Med 2010 15 299 305
30. Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sample. Yano Y, Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, Asahi K, Kurahashi I, Ohashi Y, Watanabe T, Diabetes Care 2012 35 1310 1315
31. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam growth and health longitudinal study. Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD, Arch Intern Med 2005 165 875 882 (Pubitemid 40575728)
32. Metabolic syndrome and pulse pressure. Mannucci E, Monami M, Bardini G, Sposato I, Ungar A, Pepe G, Masotti G, Marchionni N, Rotella CM, Diabetes Obes Metab 2007 9 600 602 (Pubitemid 47018526)